ScentAware and OCT in MCI vs HC
Conditions: Alzheimer Disease, Early Onset Interventions: Device: ScentAware; Device: UPSIT Sponsors: University of Wisconsin, Madison Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Conditions: Genetic Predisposition; Paraganglioma; Pheochromocytoma; ALS; Parkinson Disease; Polyneuropathies; Frontotemporal Dementia; Alzheimer Disease; Cardiomyopathy Non-ischemic; Thoracic Aortic Aneurysm Interventions: Behavioral: Behavioral nudge Sponsors: University of Pennsylvania Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2024 Category: Research Source Type: clinical trials
Investigating Neurocognitive Disorders Epidemiology
Conditions: Dementia; Cognitive Decline; Alzheimer Disease Interventions: Diagnostic Test: Plasma tau phosphorylated at Thr217; Other: Neurocognitive examination Sponsors: King Chulalongkorn Memorial Hospital; Health Systems Research Institute,Thailand Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 19, 2024 Category: Research Source Type: clinical trials
A Single Dose Escalation Study of HHT201 in Healthy Subjects
Conditions: Alzheimer Disease Interventions: Drug: Donepezil Dihydroxynaphthalate for Injection Sponsors: Shanghai Synergy Pharmaceutical Sciences Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
Next-Generation alzheImer'S Therapeutics
Conditions: Alzheimer Disease Interventions: Other: genetically encoded engineered proteins Sponsors: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
A Trial Evaluating the Effect of NIO752 on Tau Synthesis Measured by a Process Known as SILK
Conditions: Alzheimer Disease; Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 1 (Disorder); Autosomal Dominant Alzheimer Disease Due to Mutation of Presenilin 2 (Disorder); Autosomal Dominant Alzheimer Disease Due to Mutation of Amyloid Precursor Protein (Disorder) Interventions: Drug: NIO752; Other: Placebo Sponsors: University College, London; Washington University School of Medicine; University of Washington; Alzheimer ' s Association; Sigrid Rausing Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2024 Category: Research Source Type: clinical trials
The Effect of Community Intervention on Different Degrees of Dementia
Conditions: Alzheimer Disease Interventions: Behavioral: Community Intervention Sponsors: Babujinaya Cela Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
Effectiveness and Cost-Effectiveness of Cognitive Stimulation Therapy - Spain (CST-ES) in People Living With Dementia
Conditions: Dementia; Neurocognitive Disorders; Mild Cognitive Impairment Interventions: Behavioral: Cognitive Stimulation Therapy (CST) Sponsors: Instituto de Mayores y Servicios Sociales (IMSERSO); University of Castilla-La Mancha; Confederaci ón Española de Alzheimer (CEAFA) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 17, 2024 Category: Research Source Type: clinical trials
SCGs as a Proxy for Determining the Cognitive Status of Older Adults
Conditions: Mild Cognitive Impairment; Dementia; Alzheimer Disease; Healthy Aging; Cognitive Decline Interventions: Other: VibrantMinds Sponsors: University of Alberta Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People
Conditions: Alzheimer Disease Interventions: Drug: DDN-A-0101 (SAD); Drug: DDN-A-0101 (MAD); Drug: Placebo (SAD); Drug: Placebo (MAD) Sponsors: Pharmacobio Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
An Open Platform of Serious Games for Cognitive Intervention
Conditions: Mild Cognitive Impairment; Dementia; Alzheimer Disease; Aging Interventions: Device: VibrantMinds Sponsors: University of Alberta; Alberta Health services; CapitalCare Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
A Program to Reduce Inappropriate Medications Among Older Adults With Alzheimer's Disease: Implementation Phase 2
Conditions: Alzheimer Disease Interventions: Other: Educational Materials Sponsors: University of Massachusetts, Worcester; National Institute on Aging (NIA); Harvard Pilgrim Health Care; Humana Healthcare Research, Inc.; Carelon Research Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Promoting Physical Activity in Older Hispanic/Latino(a) Adults
Conditions: Sedentary Behavior; Physical Inactivity; Alzheimer Disease, Protection Against Interventions: Behavioral: De Pie Intervention; Other: Active Comparison Group: Healthy Actions And Lifestyles To Avoid Dementia (HALT-AD) Sponsors: Kaiser Permanente; University of California, San Diego Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)
Conditions: Cognitive Decline, Mild; Alzheimer Disease Interventions: Drug: Fasudil; Drug: Placebo Sponsors: Helse Stavanger HF; University of Exeter Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 12, 2024 Category: Research Source Type: clinical trials
A Light Exposure Tracker Designed to Improve Circadian Rhythms - Aim 1
Conditions: Alzheimer ' s Disease; Mild Cognitive Impairment Interventions: Device: Light goggles; Device: Orange glasses Sponsors: Icahn School of Medicine at Mount Sinai Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 10, 2024 Category: Research Source Type: clinical trials